Clinical Trials Arena March 8, 2024
As the number of approved cell and gene therapies is set to increase in the next ten years, what challenges do they present to the supply chain?
Last year, eight cell and gene therapies were approved in the US and EU, with the scope only continuing to increase. With this growth, experts gathered at Clinical Trial Supply (CTS) Europe to discuss the challenges these blockbuster treatments pose to the supply chain.
Leading the session “Current challenges in the supply chain and future trends”, global depot network director at the CRO SanaClis Allan van Konynenburg delved into trends such as artificial intelligence, blockchain, and cybersecurity, but “out of all trends, cell therapy is front and centre in terms of what’s...
Today's Sponsors
Today's Sponsor